The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review

MeSH terms

• Cost-Benefit Analysis
• Humans
• Incidence
• Motor Neuron Disease / drug therapy*
• Motor Neuron Disease / epidemiology
• Neuroprotective Agents / adverse effects
• Neuroprotective Agents / economics*
• Neuroprotective Agents / therapeutic use*
• Prevalence
• Randomized Controlled Trials as Topic
• Riluzole / adverse effects
• Riluzole / economics*
• Riluzole / therapeutic use*
• Technology Assessment, Biomedical
• Treatment Outcome
• United Kingdom / epidemiology